0001209191-21-025490.txt : 20210405 0001209191-21-025490.hdr.sgml : 20210405 20210405193233 ACCESSION NUMBER: 0001209191-21-025490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210402 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eliades George Christopher CENTRAL INDEX KEY: 0001855251 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39112 FILM NUMBER: 21807498 MAIL ADDRESS: STREET 1: C/O OYSTER POINT PHARMA, INC. STREET 2: 202 CARNEGIE CENTER, SUITE 109 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oyster Point Pharma, Inc. CENTRAL INDEX KEY: 0001720725 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 811030955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 109 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 382-9032 MAIL ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 109 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-02 0 0001720725 Oyster Point Pharma, Inc. OYST 0001855251 Eliades George Christopher C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109 PRINCETON NJ 08540 1 0 0 0 Common Stock 2021-04-02 4 A 0 19935 0.00 A 19935 D Common Stock 2021-04-02 4 A 0 1650 0.00 A 21585 D This security represents restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. 1/3 of the RSUs will vest in three equal annual installments, with 1/3 vesting on the one (1) year anniversary of April 2, 2021, and one-third (1/3) of the RSUs vesting annually thereafter on April 2, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date. 1/3 of the RSUs will vest monthly on the same day of the month beginning on April 8, 2021 until the Company's Annual Meeting of Stockholders to be held in 2021; provided, however, if all of such RSUs are not fully vested at the Company's next Annual Meeting, any such remaining RSUs will vest on the date of the Company's next Annual Meeting, in each case, subject to the Reporting Person continuing to be a service provider pursuant to the terms of the Issuer's 2019 Equity Incentive Plan through each such date. /s/ Brandon Fenn, Attorney-in-Fact 2021-04-05